0001645113-20-000131.txt : 20200910 0001645113-20-000131.hdr.sgml : 20200910 20200910200850 ACCESSION NUMBER: 0001645113-20-000131 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200901 FILED AS OF DATE: 20200910 DATE AS OF CHANGE: 20200910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cordova Ashley CENTRAL INDEX KEY: 0001822014 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 201169697 MAIL ADDRESS: STREET 1: 20 VALLEY STREAM PARKWAY, STREET 2: SUITE 300 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 3 1 wf-form3_159978291221889.xml FORM 3 X0206 3 2020-09-01 0 0001645113 NovoCure Ltd NVCR 0001822014 Cordova Ashley C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Financial Officer Ordinary Shares 7348 D Restricted Share Units 1465 D Restricted Share Units 1006 D Restricted Share Units 5314 D Restricted Share Units 5405 D Restricted Share Units 5904 D Options to Buy Ordinary Shares 15.6 2025-04-22 Ordinary Shares 13840.0 D Options to Buy Ordinary Shares 11.46 2026-02-24 Ordinary Shares 8936.0 D Options to Buy Ordinary Shares 11.44 2026-07-27 Ordinary Shares 2480.0 D Options to Buy Ordinary Shares 7.15 2027-02-21 Ordinary Shares 9752.0 D Options to Buy Ordinary Shares 47.04 2029-03-21 Ordinary Shares 14595.0 D Options to Buy Ordinary Shares 19.25 2021-07-26 2027-07-25 Ordinary Shares 7500.0 D Options to Buy Ordinary Shares 21.5 2028-02-26 Ordinary Shares 16051.0 D Options to Buy Ordinary Shares 32.02 2028-10-29 Ordinary Shares 8300.0 D Options to Buy Ordinary Shares 69.37 2030-03-02 Ordinary Shares 10422.0 D Options to Buy Ordinary Shares 84.68 2030-08-31 Ordinary Shares 11336.0 D Represents restricted share units that are scheduled to vest on February 27, 2021, subject to the reporting person's continued employment through such date. Represents restricted share units that are scheduled to vest in equal installments on each of October 30, 2020 and 2021, subject to the reporting person's continued employment through such dates. Represents restricted share units that are scheduled to vest in equal installments on each of March 22, 2021 and 2022, subject to the reporting person's continued employment through such dates. Represents restricted share units that are scheduled to vest in equal installments on each of March 3, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates. Represents restricted share units that are scheduled to vest in equal installments on each of September 1, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates. Currently exercisable. Options to buy 9,752 ordinary shares, 2 shares of which are currently exercisable and the remainder vest on February 22, 2021. Options to buy 14,595 ordinary shares, 3,649 shares of which are currently exercisable and the remaining 10,946 shares of which will vest and become exercisable in equal installments on each of March 22, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates. Options to buy 16,051 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2021 and 2022, subject to the reporting person's continued employment through such dates. Options to buy 8,300 ordinary shares will vest and become exercisable in equal installments on each of October 30, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Options to buy 10,422 ordinary shares will vest and become exercisable in equal installments on each of March 3, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates. Options to buy 11,336 ordinary shares will vest and become exercisable in equal installments on each of September 1, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates. By: /s/ Steven Robbins, Attorney in Fact for Ashley Cordova 2020-09-10